Small Stocks, Big Money™

bioAffinity Technologies (Nasdaq: BIAF) announced an impressive 217% increase in Q2 sales for its CyPath® Lung test, prompting an 85% raise in the company's full-year sales forecast. This surge surpasses their previous forecast by 75%, driven by the expanding customer base of pulmonology practices. CyPath® Lung, a noninvasive test for early lung cancer detection, is gaining traction in Texas and beyond, with private insurers now reimbursing the $1,900 test. Projected 2024 revenue for Precision Pathology Laboratory Services, including CyPath® Lung, is between $9.2 and $9.6 million, reflecting the growing market potential.

GreenPower Motor Company Inc. (Nasdaq: GP) will showcase its innovative all-electric, zero-emission school buses at the School Transportation News (STN) Expo in Reno, Nevada, from July 12 to 17, 2024. GreenPower’s President, Brendan Riley, emphasizes the company's dedication to safe and sustainable school transportation. Featured vehicles include the award-winning Type A Nano BEAST and Type D BEAST, both designed to offer maximum safety and reliability. Attendees can experience these buses firsthand during a ride and drive event on July 14. GreenPower executives will also be available for one-on-one meetings to discuss funding opportunities for school districts.

Biotricity (Nasdaq: BTCY) announced an accelerated timeline to achieving EBITDA positive by the end of 2024, propelled by strategic initiatives and technological advancements. CEO Dr. Waqaas Al-Siddiq highlighted the company's transformative fiscal 2024, marked by a 25.2% revenue increase, improved margins, and reduced operating expenses. Key drivers include the expansion of the Cardiac AI Cloud platform and strategic partnerships with Group Purchasing Organizations, covering 90% of U.S. hospitals. With recent Health Canada approval for Biocore, Biotricity is also poised for significant growth in the $1.56 billion Canadian cardiology market, and is targeting a $35 billion total addressable global market.

Spectaire Holdings (Nasdaq: SPEC) announced the appointment of Jim Lambis, VP of Buildings and Systems Engineering at UPS International, to its board of directors. Lambis, an expert in emissions management and logistics, will enhance Spectaire’s commercialization efforts with his strategic and operational expertise. CEO Brian Semkiw highlighted Lambis's potential to optimize systems and boost operational efficiencies as the company scales. With the global air quality monitoring market projected to grow from $5.1 billion in 2022 to $8.9 billion by 2030, Spectaire is poised for significant expansion under Lambis’s guidance.